Toggle Nav
mobile icon
My Cart
Close
  • Menu
  • Setting

Leukotriene Receptor

Leukotrienes receptors are divided into two types, BLT receptors and CycLT receptors. BLT receptors mediate chemoattraction. CysLT receptors mediate pro-inflammatory effects including constriction of airways ad smooth muscle contraction.

Items 11-17 of 17

Page
per page
  1. SR 2640 hydrochloride
    B6860 SR 2640 hydrochloride
    Summary: leukotriene D4 and E4 receptor antagonist
      <20.34 mg/mL
  2. Cinalukast
    B6930 Cinalukast
    Summary: CysLT1 (LTD4) leukotriene receptor antagonist
      insoluble in ethanol; <41.26 mg/mL
  3. LY 255283
    B6978 LY 255283
    Summary: BLT2 receptor antagonist
      Soluble in DMSO
  4. Zafirlukast
    B2068 Zafirlukast
    Target: Leukotriene and Related Receptors
    Summary: oral leukotriene receptor antagonist
      ≥23.9 mg/mL
  5. γ-Linolenic Acid methyl ester
    C5226 γ-Linolenic Acid methyl ester
    Summary: weak leukotriene B4 (LTB4) receptor antagonist
      ≤100 mg/mL
  6. REV 5901
    C5416 REV 5901
    Summary: antagonist of cysteinyl-leukotriene receptors
      ≤100 mg/mL
  7. γ-Linolenic Acid
    C5518 γ-Linolenic Acid
    Summary: weak LTB4 receptor antagonist
      ≤100 mg/mL

Items 11-17 of 17

Page
per page